![David Berman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Berman
Corporate Officer/Principal at
MODERNA, INC.
Net worth: 212 799 $ as of 2026-08-30
Profile
David Berman is Chief Development Officer at Moderna, Inc. since 2026.
Formerly, Dr. Berman was Executive VP & Head-Research & Development at Immunocore Holdings Plc from 2019 to 2026, Head-Immuno Oncology Franchise at AstraZeneca PLC from 2017 to 2018, Head-Early Stage Oncology Program at MedImmune LLC from 2015 to 2017, and Head-Immuno Oncology at Bristol Myers Squibb Co. from 2005 to 2015.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from The University of Texas Southwestern Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-01 | 5,859 ( 0.01% ) | 212 799 $ | 2026-08-30 |
David Berman active positions
| Companies | Position | Start |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | 2026-03-01 |
Former positions of David Berman
| Companies | Position | End |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 2026-02-26 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2017-12-31 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 2016-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2014-12-31 |
Training of David Berman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
- Stock Market
- Insiders
- David Berman
